DUBLIN–(BUSINESS WIRE)–The “Global Mammography Market Outlook 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The global mammography market is anticipated to grow with a CAGR of 8.61% over the forecast period, i.e., 2021 – 2030. The global mammography market is estimated to garner a revenue of near to USD 4530 Million by the end of … [Read more…]

MANHASSET, N.Y.–(BUSINESS WIRE)–A phase two clinical trial has shown the efficacy of famotidine, commonly known as Pepcid, in alleviating coronavirus disease 2019 (COVID-19) symptoms in adult patients. In a new study, scientists at The Feinstein Institutes for Medical Research discovered this widely used heartburn medication stimulates the vagus nerve, which suppresses cytokine storm – a … [Read more…]

MeMD marks official transition to Walmart Health family following its acquisition in 2021 SCOTTSDALE, Ariz.–(BUSINESS WIRE)–MeMD, a multi-specialty national telehealth provider, today announced its name change to Walmart Health Virtual Care as part of its official transition to the Walmart Health family. The name change marks the final stages of MeMD’s acquisition by Walmart Health, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Blood Testing Market, Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The Blood Testing Market is expected to witness a CAGR of 5.4% during the forecast period. This report focuses on the Blood Testing market revenue at the global, regional, and company levels. From a global perspective, this report represents … [Read more…]

LOS ANGELES–(BUSINESS WIRE)–Global Coalition for Adaptive Research, the U.S. Sponsor of REMAP-COVID, announced that Eisai has ended the evaluation of eritoran in the REMAP-COVID study. Eritoran, an investigational TLR-4 antagonist discovered and developed by Eisai, was selected for evaluation because it was hypothesized to suppress the over-production and release of various pro-inflammatory mediators (“cytokine storm”) … [Read more…]

— TAC-001 will be the First Candidate from Tallac’s Novel Toll-like Receptor Agonist Antibody Conjugate (TRAAC) Platform to Enter Clinical Trials — TAC-001 Integrates B cells and TLR9 Activation to Trigger Innate and Adaptive Anti-tumor Immune Responses — Tallac Plans to Initiate a Phase 1/2 Clinical Study of Systemically Administered TAC-001 for Patients with Advanced … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades)), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End-user (Hospital, Clinical Labs), and Region – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The microtomes market is projected to reach USD 585.2 million by 2027 from USD 425.4 million … [Read more…]

Alexandra Powell-Smith, PhD, Head of regulatory affairs Hasnae Niang, Head of Quality Thierry Menguy, PhD, Head of CMC activities Valérie Bouchara, PhD, Head of clinical operations PARIS–(BUSINESS WIRE)–LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms of cancer, announces the appointment of its regulatory, quality, CMC and clinical team. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Antibody Therapy Market” report has been added to ResearchAndMarkets.com’s offering. A recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the … [Read more…]

Join health system leaders and industry SMEs to discuss achieving ROI from AI-based solutions for system wide impact SANTA CLARA, Calif.–(BUSINESS WIRE)–LeanTaaS, Inc., a leading Silicon Valley-based technology innovator that transforms core processes to improve patient access and operational performance, today announced the next event in its Transform series. Hosted in partnership with Becker’s Healthcare, … [Read more…]